Dimerix Limited
Dimerix Limited (DXB.AX) Financial Performance & Income Statement Overview
Analyze Dimerix Limited (DXB.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Dimerix Limited (DXB.AX) Income Statement & Financial Overview
Analyze Dimerix Limited’s DXB.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $450418.00 | $133060.00 | $8.98M | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $450418.00 | $133060.00 | $8.98M | $0.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.00 |
| R&D Expenses | $16.02M | $5.08M | $11.89M | $8.59M |
| SG&A Expenses | $2.73M | $1.82M | $1.25M | $1.10M |
| Operating Expenses | $18.75M | $6.90M | $13.14M | $9.68M |
| Total Costs & Expenses | $18.75M | $6.90M | $13.14M | $9.68M |
| Interest Income | $138035.00 | $37977.00 | $10240.00 | $26547.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4026.00 | $2247.00 | $2778.00 | $1715.00 |
| EBITDA | -$10.36M | -$6.71M | -$4.19M | -$9.63M |
| EBITDA Ratio | -$23.001 | -$50.42 | -$0.47 | $0.00 |
| Operating Income | -$18.30M | -$6.76M | -$13.14M | -$9.68M |
| Operating Income Ratio | -$40.62 | -$50.83 | -$1.46 | $0.00 |
| Other Income/Expenses (Net) | $7.89M | $90463.00 | $8.94M | $75651.00 |
| Income Before Tax | -$10.40M | -$6.67M | -$4.19M | -$9.61M |
| Income Before Tax Ratio | -$23.09 | -$50.15 | -$0.47 | $0.00 |
| Income Tax Expense | $0.00 | $52486.00 | $8.93M | $49104.00 |
| Net Income | -$10.40M | -$6.67M | -$4.19M | -$9.61M |
| Net Income Ratio | -$23.09 | -$50.15 | -$0.47 | $0.00 |
| EPS | -$0.02 | -$0.02 | -$0.01 | -$0.03 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.01 | -$0.03 |
| Weighted Avg Shares Outstanding | $500.10M | $405.74M | $336.72M | $326.57M |
| Weighted Avg Shares Outstanding (Diluted) | $500.08M | $405.74M | $336.72M | $326.57M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q2 2023 to $450418.00 in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to N/A in Q2 2023. Operating income hit -$18.30M last quarter, sustaining a consistent -4062% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$10.36M. Net income dropped to -$10.40M, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan